Hawkins Inc
8 nominees · 3 ballot items.
Election of eight directors; ratification of Deloitte & Touche LLP as Hawkins, Inc.'s independent registered public accounting firm for the fiscal year ending March 29, 2026; and an advisory, non-binding vote to approve the compensation of Hawkins, Inc.'s named executive officers.
Follow how the vote landed and what changed on Hawkins Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of eight directors
ManagementBoard: FORElection of eight director nominees named in the proxy statement to serve for the ensuing year.
- 2
Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm
ManagementBoard: FORRatification of Deloitte & Touche LLP as Hawkins, Inc.'s independent registered public accounting firm for the fiscal year ending March 29, 2026.
- 3
Advisory vote to approve executive compensation
ManagementBoard: FORNon-binding advisory vote to approve the compensation of Hawkins, Inc.'s named executive officers as disclosed in the proxy statement.
Nominees on the ballot8
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 10.5% | 2,185,167 | $336M |
| 2 | KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 5.9% | 1,238,536 | $190M |
| 3 | STATE STREET CORP | 5.0% | 1,043,806 | $160M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 4.1% | 851,642 | $131M |
| 5 | BlackRock, Inc. | 2.8% | 585,909 | $90M |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.5% | 524,680 | $81M |
| 7 | DIMENSIONAL FUND ADVISORS LP | 2.3% | 484,761 | $74M |
| 8 | WASATCH ADVISORS LP | 2.3% | 469,672 | $72M |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 449,412 | $69M |
| 10 | BOWEN HANES CO INC | 1.8% | 380,520 | $58M |
Other Basic Materials sector meetings6
Upcoming shareholder meetings at Hawkins Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Hawkins Inc 2025 annual meeting?
- Hawkins Inc (HWKN) holds its 2025 annual shareholder meeting on Wednesday, July 30, 2025.
- What is the record date for the Hawkins Inc 2025 meeting?
- The record date for the Hawkins Inc 2025 meeting is Friday, June 6, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Hawkins Inc's 2025 meeting?
- The board is presenting 8 director nominees at the Hawkins Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Hawkins Inc 2025 meeting?
- Shareholders will vote on 3 proposals at the Hawkins Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.